Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gerresheimer AGGRRMF 64 Equity-to-Asset is 0.24 as of Nov. 2025, which is 29% below its 10-year median of 0.34. GuruFocus rates GRRMF with a GF Score™ of 64/100 and a GF Value™ of $191.51 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Gerresheimer AG ranks worse than 87.19% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Gerresheimer AG's Total Stockholders Equity for the quarter that ended in Nov. 2025 was $1,250 Mil. Gerresheimer AG's Total Assets for the quarter that ended in Nov. 2025 was $5,194 Mil.
Therefore, Gerresheimer AG's Equity to Asset Ratio for the quarter that ended in Nov. 2025 was 0.24.
The historical rank and industry rank for Gerresheimer AG's Equity-to-Asset or its related term are showing as below:
GRRMF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.24 Med: 0.34 Max: 0.42
Current: 0.24
During the past 13 years, the highest Equity to Asset Ratio of Gerresheimer AG was 0.42. The lowest was 0.24. And the median was 0.34.
GRRMF's Equity-to-Asset is ranked worse than 87.19% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs GRRMF: 0.24
Gerresheimer AG (OTCPK:GRRMF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Gerresheimer AG Equity-to-Asset Related Terms
Gerresheimer AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRRMF vs ISRG, BDX, RMD: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Gerresheimer AG's Equity to Asset Ratio for the fiscal year that ended in Nov. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (GRRMF) has a Equity-to-Asset of 0.24 as of Nov. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Gerresheimer AG and its competitors. This is 29% below median its historical median of 0.34. Over the past decade, Gerresheimer AG's Equity-to-Asset has ranged from 0.24 to 0.42. According to the industry distribution chart, Gerresheimer AG ranks #742 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 87.2%.
Is Gerresheimer AG's Equity-to-Asset too high?
Gerresheimer AG's current Equity-to-Asset of 0.24 is 29% below median its 10-year median of 0.34. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 0.42. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Gerresheimer AG's value of 0.24 is 62.5% below this industry median. Based on the distribution chart, Gerresheimer AG ranks #742 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Gerresheimer AG has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #742 out of 851 companies for Equity-to-Asset. This places Gerresheimer AG in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Gerresheimer AG's value of 0.24 is 62.5% below this benchmark. Historically, Gerresheimer AG's own Equity-to-Asset has ranged from 0.24 to 0.42 over the past decade. While the company's 10-year median is 0.34 vs. the industry median of 0.64, Gerresheimer AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current Equity-to-Asset of 0.24 is 62.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current Equity-to-Asset is 0.24, which is 29% below median its own 10-year median of 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $191.51, compared to a current price of $32.20 — trading 83.2% below its estimated fair value. The current Equity-to-Asset is 0.24, which is 29% below median its 10-year median of 0.34 and 62.5% below the Medical Devices & Instruments industry median of 0.64. Gerresheimer AG's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Equity-to-Asset is 0.24 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $32.20 is trading 83.2% below its estimated GF Value™ of $191.51.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
Equity-to-Asset: 0.24 (29% below median its 10-year median of 0.34)
GF Value™: $191.51 vs. price of $32.20 (83.2% below fair value)
Industry Position: 62.5% below the Medical Devices & Instruments median (#742 of 851)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
64GF Score
Get the complete analysis for GRRMF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
